U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

267B1, PC3M, LNCaP Methylation Profile vs. mRNA Expression Level

(Submitter supplied) Two prostate immortalized cell lines, 267B1, RWPE-1, Ml-csv40, and five prostate cancer cell lines, PC3, PC3M, PC3M-Pro4, PC3M-LN4 and LNCaP are included in this experiment. Their methylation profile are detected using human promoter array (v11). mRNA expression level are profiled with Affymetrix U133A Arrays for 267B1 and PC3M. Keywords: other
Organism:
Homo sapiens
Type:
Expression profiling by array; Methylation profiling by array
Platforms:
GPL864 GPL80 GPL96
14 Samples
Download data
Series
Accession:
GSE951
ID:
200000951
2.

RNA-Seq anlalysis of prostate cancer cell lines using Next Generation Sequencing

(Submitter supplied) Beginning with precursor lesions, aberrant DNA methylation marks the entire spectrum of prostate cancer progression. We mapped the global DNA methylation patterns in selected prostate tissues and cell lines using Methylplex-Next Generation Sequencing (M-NGS). Hidden Markov Model based next generation sequence analysis identified ~68,000 methylated regions per sample. While global CpG Island (CGI) methylation was not differential between benign adjacent and cancer samples, overall promoter CGI methylation increased from ~12.6% in benign samples to 19.3% and 21.8% in localized and metastatic cancer tissues, respectively. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platforms:
GPL9052 GPL9115
11 Samples
Download data: BAM
3.

Deep sequencing reveals distinct patterns of DNA methylation and transcript isoform regulation in prostate cancer

(Submitter supplied) Beginning with precursor lesions, aberrant DNA methylation marks the entire spectrum of prostate cancer progression. We mapped the global DNA methylation patterns in selected prostate tissues and cell lines using Methylplex-Next Generation Sequencing (M-NGS). Hidden Markov Model based next generation sequence analysis identified ~68,000 methylated regions per sample. While global CpG Island (CGI) methylation was not differential between benign adjacent and cancer samples, overall promoter CGI methylation increased from ~12.6% in benign samples to 19.3% and 21.8% in localized and metastatic cancer tissues, respectively. more...
Organism:
Homo sapiens
Type:
Expression profiling by array; Methylation profiling by genome tiling array; Methylation profiling by high throughput sequencing; Expression profiling by high throughput sequencing
4 related Platforms
39 Samples
Download data: BAM, TXT
Series
Accession:
GSE27619
ID:
200027619
4.

DNA methylation analysis of prostate cancer cell lines and tissues using Next Generation Sequencing

(Submitter supplied) Beginning with precursor lesions, aberrant DNA methylation marks the entire spectrum of prostate cancer progression. We mapped the global DNA methylation patterns in prostate tissues (n=17) and cells (n=2) from fifty nanograms of genomic DNA using Methylplex-Next Generation Sequencing (M-NGS). A Hidden Markov Model (HMM)-based algorithm previously used for Chip-Seq data analysis(http://www.sph.umich.edu/csg/qin/HPeak) was used to locate peaks from mapped reads obtained in each sequencing run. more...
Organism:
Homo sapiens
Type:
Methylation profiling by high throughput sequencing
Platform:
GPL9115
9 Samples
Download data: TXT
Series
Accession:
GSE27618
ID:
200027618
5.

Agilent CpG array analysis of Methylplex-library of prostate cancer cell lines

(Submitter supplied) Beginning with precursor lesions, aberrant DNA methylation marks the entire spectrum of prostate cancer progression. We mapped the global DNA methylation patterns in selected prostate tissues and cell lines using Methylplex-Next Generation Sequencing (M-NGS). Hidden Markov Model based next generation sequence analysis identified ~68,000 methylated regions per sample. While global CpG Island (CGI) methylation was not differential between benign adjacent and cancer samples, overall promoter CGI methylation increased from ~12.6% in benign samples to 19.3% and 21.8% in localized and metastatic cancer tissues, respectively. more...
Organism:
Homo sapiens
Type:
Methylation profiling by genome tiling array
Platform:
GPL4126
2 Samples
Download data: TXT
Series
Accession:
GSE27617
ID:
200027617
6.

Agilent expression analysis of prostate cancer tissue samples

(Submitter supplied) Beginning with precursor lesions, aberrant DNA methylation marks the entire spectrum of prostate cancer progression. We mapped the global DNA methylation patterns in selected prostate tissues and cell lines using Methylplex-Next Generation Sequencing (M-NGS). Hidden Markov Model based next generation sequence analysis identified ~68,000 methylated regions per sample. While global CpG Island (CGI) methylation was not differential between benign adjacent and cancer samples, overall promoter CGI methylation increased from ~12.6% in benign samples to 19.3% and 21.8% in localized and metastatic cancer tissues, respectively. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL4133
13 Samples
Download data: TXT
Series
Accession:
GSE27616
ID:
200027616
7.

Agilent expression analysis of LNCaP cells following 5'aza-treatment

(Submitter supplied) Beginning with precursor lesions, aberrant DNA methylation marks the entire spectrum of prostate cancer progression. We mapped the global DNA methylation patterns in selected prostate tissues and cell lines using Methylplex-Next Generation Sequencing (M-NGS). Hidden Markov Model based next generation sequence analysis identified ~68,000 methylated regions per sample. While global CpG Island (CGI) methylation was not differential between benign adjacent and cancer samples, overall promoter CGI methylation increased from ~12.6% in benign samples to 19.3% and 21.8% in localized and metastatic cancer tissues, respectively. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL4133
4 Samples
Download data: TXT
Series
Accession:
GSE25346
ID:
200025346
8.

MeDIP-Chip of PrEC, LnCAP, and PC3 cells treated with vehicle control, sulforaphane, or 3,3’-diindolylmethane

(Submitter supplied) Effects of sulforaphane and 3,3’-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells This study was undertaken to determine the genome-wide effects of sulforaphane (SFN) and 3,3’-diindolylmethane (DIM) on promoter methylation in normal prostate epithelial cells and prostate cancer cells. Nimblegen Human DNA Methylation 3x720K CpG Island Plus RefSeq Promoter Array was used in this study. more...
Organism:
Homo sapiens
Type:
Methylation profiling by genome tiling array
Platform:
GPL17148
27 Samples
Download data: GFF, PAIR
Series
Accession:
GSE47017
ID:
200047017
9.

Detection of novel amplification units in prostate cancer

(Submitter supplied) Genome-wide screening for regions of genetic gains and losses on nine prostate cancer cell lines (PC3, DU145, LNCaP, CWR22, and derived sublines) was carried out using comparative genomic hybridization on a 35 K longmer oligonucleotide microarray (arrayCGH). Compared to conventional chromosomal CGH more deletions and small regions of gains, particularly in pericentromeric regions and regions next to the telomers, were detected. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by array
Platform:
GPL5046
11 Samples
Download data: TXT
Series
Accession:
GSE7376
ID:
200007376
10.

Global Reactivation of Epigenetically Silenced Genes in Prostate Cancer

(Submitter supplied) Transcriptional silencing associated with aberrant promoter hypermethylation is a common mechanism of inactivation of tumor suppressor genes in cancer cells.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL9452
8 Samples
Download data: XLS
Series
Accession:
GSE18573
ID:
200018573
11.

Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression

(Submitter supplied) Background: Global DNA methylation alterations are hallmarks of cancer. The tumor-suppressive TET enzymes, which are involved in DNA demethylation, are decreased in prostate cancer (PCa); in particular, TET2 is specifically targeted by androgen-dependent mechanisms of repression in PCa and may play a central role in carcinogenesis. Thus, identification of key genes targeted by TET2 dysregulation may provide further insight into cancer biology. more...
Organism:
Homo sapiens
Type:
Methylation profiling by high throughput sequencing; Expression profiling by high throughput sequencing
Platform:
GPL16791
12 Samples
Download data: TXT
12.

Genome-wide screen for promoter methylation in NSCLC identifies novel methylation markers for multiple malignancies

(Submitter supplied) BACKGROUND: Promoter hypermethylation coupled with loss of heterozygosity at the same locus results in loss of gene function in many tumor cells. The "rules" governing which genes are methylated during the pathogenesis of individual cancers, how specific methylation profiles are initially established, or what determines tumor type-specific methylation are unknown. However, DNA methylation markers that are highly specific and sensitive for common tumors would be useful for the early detection of cancer, and those required for the malignant phenotype would identify pathways important as therapeutic targets. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
7 Samples
Download data: CEL
Series
Accession:
GSE6695
ID:
200006695
13.

A Genome-wide Screen for Hypermethylated Genes in Lung Cancer

(Submitter supplied) Abstract Background: Promoter hypermethylation coupled with loss of heterozygosity at the same locus results in loss of gene function in many tumor cells. The “rules” governing which genes are methylated during the pathogenesis of individual cancers, how specific methylation profiles are initially established, or what determines tumor-type specific methylation are unknown. However, DNA methylation markers that are highly specific and sensitive for common tumors would be useful for the early detection of cancer, and those required for the malignant phenotype identify pathways important as therapeutic targets. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
42 Samples
Download data: CEL
Series
Accession:
GSE5816
ID:
200005816
14.

DNA methylation and expression profiling study for prostate cancer

(Submitter supplied) Microarray-based DNA methylation and gene expression profiling was carried out using a panel of prostate cancer cell lines (LNCaP-FGC, DU-145, and PC-3) and the control normal prostate RWPE1 cell line. The identification of prostate cancer-specific methylation markers was based on the following criteria: a difference in DNA methylation level (β) of at least 0.5, and at least a 2-fold difference in expression level between cancer and control cells. more...
Organism:
Homo sapiens
Type:
Expression profiling by array; Methylation profiling by array
Platforms:
GPL6947 GPL8490
8 Samples
Download data: TXT
Series
Accession:
GSE23388
ID:
200023388
15.

Expression data from LCM captured prostate cancer cells

(Submitter supplied) The prostate represents a complex mix of cell types and there is a need to analyze distinct cell populations to better understand their potential interactions. This study of cell-type specific gene expression patterns will contribute to understanding of how tumor epithelial cells may be affected by adjacent interstitial stromal cells within the tumor microenvirnonment. LCM and microarray analysis were used to identify gene expression patterns in prostate cancer epithelial and interstitial stromal cell populations. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL571
6 Samples
Download data: CEL, CHP
Series
Accession:
GSE20758
ID:
200020758
16.

Melanoma progression model:DAC-mediated gene expression

(Submitter supplied) Melanoma progression model:DAC-mediated gene expression Keywords: other
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS1440
Platform:
GPL80
6 Samples
Download data
Series
Accession:
GSE1793
ID:
200001793
17.

Melanoma progression model: Differential Gene Expression

(Submitter supplied) Melanoma progression model Keywords: other
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL80
6 Samples
Download data
Series
Accession:
GSE1792
ID:
200001792
18.
Full record GDS1440

Melanoma cell lines treated with a DNA methylase inhibitor

Analysis of a poorly tumorigenic melanoma cell line and its 3 highly aggressive derivative lines after treatment with 2'-deoxy-5-azacytidine (DAC), a DNA methyltransferase inhibitor. Results suggest multiple markers for melanoma progression that are regulated by DNA methylation.
Organism:
Homo sapiens
Type:
Expression profiling by array, count, 2 agent, 4 cell line, 2 cell type sets
Platform:
GPL80
Series:
GSE1793
6 Samples
Download data
DataSet
Accession:
GDS1440
ID:
1440
19.

DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer

(Submitter supplied) Genome wide DNA methylation profiling of normal and tumor prostate samples, as well as cultured primary prostate cells overexpressing DNA Methyltransferases (DNMTs) and EZH2 Candidate gene based studies have identified a handful of aberrant CpG DNA methylation events in prostate cancer. However, DNA methylation profiles have not been compared on a large scale between prostate tumor and normal prostate, and the mechanisms behind these alterations are unknown. more...
Organism:
Homo sapiens
Type:
Methylation profiling by array
Platform:
GPL8490
193 Samples
Download data: TXT
Series
Accession:
GSE26126
ID:
200026126
20.

Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix

(Submitter supplied) A microarray-based strategy using digestion with the methylation-sensitive restriction enzyme HpaII, ligation, and PCR, was performed to assess the DNA methylation status of promoter regions in Six human cervical adenocarcinomas (ACA) and four squamous cell carcinomas (SCC). Two array platforms were used; an array of 11,994 ~1.5kb PCR products from 10,445 promoter regions, and an array of 355,264 oligonucleotides for 18,212 HpaII fragments in 12,617 promoter regions. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by array
Platforms:
GPL6442 GPL6441 GPL8286
24 Samples
Download data: TXT
Series
Accession:
GSE15113
ID:
200015113
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=3|qty=2|blobid=MCID_672e98d1ad0a37579f51dfa7|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center